實驗室自動化系統導入檢驗試劑市場之評估及作法 / Hospital laboratories in Taiwan are confronted by the cost and quality challenges as the overall healthcarec environments are getting more rigorous. Introducing automation solution to the laboratory is one of the best ways to lower costs and improve quality of laboratory operation. Siemens Healthcare Diagnostics (SHD) is planning to launch Laboratory Automation System (LAS) in Taiwan market to address customer demand. Moreover SHD can further extend the business coverage by the lab integration while pursing automation.
SHD identified non-public medical centers as LAS target market by considering the relative bigger market share and more flexible procurement process. As the prospects are limited at around 20 hospitals, the sales and promotion strategy will be on project based to custom-made our solution to individual hospital. SHD will not treat LAS product line as a revenue generator. Instead the LAS product is the integration tool for SHD to further extend the business in the lab. SHD will maintain current distribution channel and corporately promote the new product along with the exclusive distributor. However SHD intends to invest more on marketing and sales headcount in the middle term to ensure high customer satisfaction among these VIP accounts.
The sales goal of this new product launch is to achieve one unit LAS installation in the first year and two units in year 2 to 5 in a row. CAGR of this new product line will be at 44.15% during the first 5 years.
| Identifer | oai:union.ndltd.org:CHENGCHI/G0094933009 |
| Creators | 邱禎祥, Chiu, Jack |
| Publisher | 國立政治大學 |
| Source Sets | National Chengchi University Libraries |
| Language | 英文 |
| Detected Language | English |
| Type | text |
| Rights | Copyright © nccu library on behalf of the copyright holders |
Page generated in 0.0011 seconds